Inventor · disambiguated record
Koji Morita
Also filed as: MORITA KOJI
16 granted patents·5 pending applications·582 citations·filing 2001–2024
94Inventor score
Top patents by PatentIndex Score
21 records- 0198US7314923B2Nucleoside and oligonucleotide analoguesDAIICHI SANKYO CO LTD·Filed 2003·Granted Jan 1, 2008·214 cites·12 claims
- 0297US9808537B2Antibody-drug conjugateDAIICHI SANKYO CO LTD·Filed 2016·Granted Nov 7, 2017·44 cites·18 claims
- 0397US7335765B2Nucleoside and oligonucleotide analoguesDAIICHI SANKYO CO LTD·Filed 2001·Granted Feb 26, 2008·174 cites·60 claims
- 0496US10973924B2Antibody-drug conjugateDAIICHI SANKYO CO LTD·Filed 2018·Granted Apr 13, 2021·9 cites·2 claims
- 0596US10195288B2Antibody-drug conjugateDAIICHI SANKYO CO LTD·Filed 2013·Granted Feb 5, 2019·43 cites·35 claims
- 0696US7816333B2Oligonucleotide analogues and methods utilizing the sameDAIICHI SANKYO CO LTD·Filed 2007·Granted Oct 19, 2010·43 cites·19 claims
- 0795US10155821B2Anti-HER2 antibody-drug conjugateDAIICHI SANKYO CO LTD·Filed 2016·Granted Dec 18, 2018·17 cites·8 claims
- 0893US11795236B2Method for treating cancer comprising administration of anti-HER2 antibody-drug conjugateDAIICHI SANKYO CO LTD·Filed 2018·Granted Oct 24, 2023·6 cites·12 claims
- 0993US11584800B2Method of treating cancer comprising administration of anti-HER2 antibody-drug conjugateDAIICHI SANKYO CO LTD·Filed 2020·Granted Feb 21, 2023·2 cites·7 claims
- 1091US8957201B2Oligonucleotide analogues and methods utilizing the sameKANEKO MASAKATSU·Filed 2010·Granted Feb 17, 2015·23 cites·13 claims
- 1189US2025049782A1Antibody-drug conjugateDAIICHI SANKYO CO LTD·Filed 2024·Application pending·0 cites
- 1287US12186310B2Antibody-drug conjugateDAIICHI SANKYO CO LTD·Filed 2023·Granted Jan 7, 2025·0 cites·1 claims
- 1385US11633493B2Antibody-drug conjugateDAIICHI SANKYO CO LTD·Filed 2020·Granted Apr 25, 2023·1 cites·14 claims
- 1483US2024026030A1Method of treating cancer comprising administration of anti-her2 antibody-drug conjugateDAIICHI SANKYO CO LTD·Filed 2023·Application pending·0 cites
- 1582US7651999B22′, 5′-oligoadenylate analogsSANKYO CO·Filed 2005·Granted Jan 26, 2010·4 cites·18 claims
- 1680US7994152B2Method of treating a cancer by administering A 2′,5′-oligoadenylate analogSANKYO CO·Filed 2009·Granted Aug 9, 2011·2 cites·16 claims
- 1756US2010209490A1Immunoliposome inducing apoptosis into cell expressing death domain-containing receptorDAIICHI SANKYO CO LTD·Filed 2008·Application pending·0 cites
- 1856US2011269942A1Antibodies modified with hydrophobic moleculeDAIICHI SANKYO CO LTD·Filed 2008·Application pending·0 cites
- 1954US2023144876A1Immune inducer containing polynucleotide-peptide conjugate and pharmaceutical composition containing sameTHE UNIV OF KITAKYUSHU·Filed 2021·Application pending·0 cites
- 2043US9738681B2Intermediate for production of nucleoside analog and method for producing the sameDAIICHI SANKYO CO LTD·Filed 2013·Granted Aug 22, 2017·0 cites·14 claims
- 2138US11185594B2(Anti-HER2 antibody)-drug conjugateDAIICHI SANKYO CO LTD·Filed 2015·Granted Nov 30, 2021·0 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when Koji Morita files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →